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Abstract
Kawasaki disease (KD) is an acute systemic vasculitis syndrome that primarily affects infants and young children. Its etiology
is unknown; however, epidemiological findings suggest that genetic predisposition underlies disease susceptibility. Taiwan
has the third-highest incidence of KD in the world, after Japan and Korea. To investigate novel mechanisms that might
predispose individuals to KD, we conducted a genome-wide association study (GWAS) in 250 KD patients and 446 controls
in a Han Chinese population residing in Taiwan, and further validated our findings in an independent Han Chinese cohort of
208 cases and 366 controls. The most strongly associated single-nucleotide polymorphisms (SNPs) detected in the joint
analysis corresponded to three novel loci. Among these KD-associated SNPs three were close to the COPB2 (coatomer
protein complex beta-2 subunit) gene: rs1873668 (p=9.52 610
25), rs4243399 (p=9.93 610
25), and rs16849083
(p=9.93610
25). We also identified a SNP in the intronic region of the ERAP1 (endoplasmic reticulum amino peptidase 1)
gene (rs149481, pbest=4.61610
25). Six SNPs (rs17113284, rs8005468, rs10129255, rs2007467, rs10150241, and rs12590667)
clustered in an area containing immunoglobulin heavy chain variable regions genes, with pbest-values between 2.08610
25
and 8.93610
26, were also identified. This is the first KD GWAS performed in a Han Chinese population. The novel KD
candidates we identified have been implicated in T cell receptor signaling, regulation of proinflammatory cytokines, as well
as antibody-mediated immune responses. These findings may lead to a better understanding of the underlying molecular
pathogenesis of KD.
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Introduction
Kawasaki disease (KD) is the commonest cause of acquired
heart disease among children in developed/industrialized coun-
tries. The incidence of KD varies between different countries, with
Asian countries having a higher incidences than Western
countries. Japan has the highest annual incidence in the world
with 200 KD cases per 100,000 children under age 5 [1,2],
followed by Korea, with an annual incidence of 113.1 KD cases
per 100,000 children under 5 years of age [3]. The incidence in
Taiwan is 69 KD cases per 100,000 children under age 5 [4,5],
which ranks third after Japan and Korea. KD is an acute, self-
limiting vasculitis of infants and children. Symptoms include
prolonged fever that is unresponsive to antibiotics, polymorphous
skin rash, swollen glands, red eyes, inflammation of the mouth,
extensive rash, and swollen and red hands and feet. Characteristic
peeling of the skin on fingers and toes occurs during convalescence
[6]. Coronary aneurysms develop in 15%–25% of untreated
children [6,7]. The cause of this disease is currently unknown,
although clinical and epidemiological features strongly suggest that
an infectious agent triggers KD and genetic predisposition may
underlie its etiology. It has been proposed that an inflammatory
stimulus sets in motion a cascade of events that leads to host
immune dysregulation in genetically predisposed individuals.
During the acute stage of KD, infiltration of CD8-positive T cells
and macrophages, activation of vascular endothelial cells, and
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e16853increased serum levels of proinflammatory cytokines lead to
inflammation and injury of blood vessels [8,9]. Thus, identification
of predisposing genetic factors would greatly facilitate understand-
ing of the disease etiology and pathophysiology.
A number of genes that participate in immune-regulatory
responses as well as cardiovascular-related loci have been
extensively studied for an association with KD susceptibility or
disease outcome using the candidate gene approach [10]. Several
candidate genes have been examined in independent cohorts of
the same or different ethnicity; however, the results are often
conflicting. Most previous studies have been carried out on a single
small cohort of KD patients, and findings were reported without
validation in additional case-control sets. There have been few
genome-wide studies of this disease. A genome-wide linkage
analysis conducted with Japanese KD sib-pair samples revealed
several linked regions, and led to the identification of a functional
polymorphism in the ITPKC (inositol 1,4,5-triphosphate 3-kinase
C) gene [11,12]. A genome-wide association study (GWAS)
conducted in an international cohort of Caucasian patients
identified variants of genes with functions potentially related to
inflammation, apoptosis, and cardiovascular pathology with
NAALADL2 (rs17531088, pcombined=1.13610
-6 and ZFHX3
(rs7199343, pcombined=2.37610
-6 most significantly associated
[13].
To identify novel mechanisms that might predispose patients to
KD, we conducted a two-stage GWAS scan for KD in a Han
Chinese population residing in Taiwan. In this paper, we present
results of the first GWAS for KD in a Han-Chinese population,
and identify new KD susceptibility loci that are involved in the
immune response and are associated with increased risk of KD.
Results
Data quality
Individual call rates were greater than 0.95 for all subjects
genotyped in this study. The average individual call rate was 0.993
(standard deviation [SD] =0.005). Of the 906,955 SNPs on the
Affymetrix 6.0 SNP chip, 96,955 were non-polymorphic in both
KD cases and controls; 27,779 had a call rate of ,95%; 30,080
had an overall minor allele frequency (MAF) ,5% and a total call
rate ,99%; and 28,093 exhibited a significant deviation from
Hardy–Weinberg equilibrium compared to the control group
(p,10
27). A total of 723,638 SNPs (79.8%) that passed a quality
control filter with an average SNP call rate of 0.996 (SD=0.006)
were included in the GWAS (Table S1).
Assessment of population stratification
Multidimensional scaling analysis (Figure S1) and results of
permutation tests for between-KD and control group identity-by-
state (IBS) differences (p=0.460) suggested that strong population
stratification was absent. Furthermore, the variance inflation
factor for genomic control, l=1.118, also indicated that no very
strong stratification existed. The IBS sharing method implemented
in PLINK showed no encrypted family relationships among cases
and controls.
GWAS and cross-platform validation
The analysis was first performed with samples from 250
individuals with KD and 446 controls (Table S2). A total of 141
of the 723,638 SNPs were associated with KD (p,10
24) (Figure 1).
Seventy-four of 141 SNPs with significant SNPs on the same LD
block (the LD blocks were estimated based on Asian HapMap),
good Affymetrix calling of clustering in both cases and controls,
and located in (or within 500 kb) of known genes were chosen for
cross-platform validation using Sequenom MassARRAY. Of these
74 SNPs, 57 that reached an overall 99% consistency and had
association pbest-values ,10
24 with any genotype, allele, trend,
dominant, or recessive models in both platforms were retained
after cross-platform validation (Table S3).
Replication of identified SNPs in a follow-up cohort
We then genotyped an additional 208 cases and 366 controls for
the 57 validated KD-associated SNPs. The results of this Stage 2
analysis and the joint analysis of 458 cases and 812 controls are
listed in Table S3. Twelve of 57 SNPs had nominal p-values ,0.05
in the replication cohort. Thirteen SNPs with the most significant
association with KD in the joint analysis (pbest,10
24) are listed in
Table1 and highlighted in Table S3. Of these 13 SNPs, 10 in three
regions with consecutive surrounding significant SNPs were
selected; these are described below. The estimated recombination
rates based on the Chinese HapMap and the association results
from GWAS in the three regions are shown in Figure 2.
The SNPs, rs1873668 (pbest=9.52610
25), rs4243399 (pbest=
9.93610
25), and rs16849083 (pbest=9.93610
25) are located in
chromosome region 3q23 and were associated with KD in joint
analysis (pbest,10
24; Table 1). Their nearby SNPs, rs1873666
(pbest=0.000123), rs4894410 (pbest=0.000103), and rs16849065
(pbest=0.000243), also showed significant association in the joint
analysis (Table S3). These SNPs were located to a linkage
disequilibrium (LD) block containing genes encoding mitochon-
drial ribosomal protein S22 (MRPS22), coatomer protein complex
beta-2 subunit (COPB2), and retinol-binding protein 2 (PBP2;
Figures 2A and S2).
rs149481, with a pbest-value of 4.61610
25 in the joint analysis, is
located in chromosome region 5 15q (Table 1) within the intronic
region of the ERAP1 (endoplasmic reticulum amino peptidase 1)
gene (Figure 2B). The nearby SNP, rs27042, showed an
association with KD in the joint analysis (pbest=0.000153; Table
S3) and is also located in the same intronic region of the ERAP1
gene (Figure 2B). ERAP1 plays a role in peptide trimming in the
generation of most HLA (human leukocyte antigen) class I–
binding peptides, and is also involved in regulating proinflamma-
tory cytokine signaling through cleavage of cytokine cell surface
receptors.
A cluster of variants was located in an LD block of chromosome
region 14 q32.33 (Figure S2). This cluster included rs17113284
(pbest=1.08610
25), rs8005468 (pbest=8.93610
26), rs10129255
(pbest=1.14610
25), rs2007467 (pbest=1.28610
25), rs10150241
(pbest=1.08610
25), and rs12590667 (pbest=1.27610
25) (Tables 1
and S3). This region contains genes coding for immunoglobulin
heavy chain variable regions (Figure 2C).
Comparison of our results with previously identified
candidate regions
Some genes with known functions or roles related to KD
pathophysiology have been intensively studied for an association
with KD using the candidate gene approach. Therefore, we
examined the SNPs in these gene regions in our GWAS to identify
their association with KD in the Han population. HLA-Bw22
(Bw54) has been associated with KD in a Japanese population
[14], and a SNP located in the HLA-E gene was suggested to be
associated with KD in the Han Chinese population [15].
Additionally, a SNP for the TNF-a 308A variant was shown to
be associated with susceptibility to KD in a Chinese population
[16], and a Taiwanese group reported that an insertion in the
angiotensin I converting enzyme was associated with KD
susceptibility [17]. More importantly, an association of the ITPKC
(inositol 1,4,5-trisphosphate 3-kinase C) gene region with KD
Kawasaki Disease-Susceptibility Genes
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cohorts, and the encoded protein was shown to be involved in T-
cell activation in an in vitro cell system [12]. Our results showed
that none of the SNPs located in or near these gene regions had
2log10 (pbest) values greater than 4 in our GWAS. However, some
SNPs located in HLA-A, HLA-B, TNF-a, and ITPKC regions did
show a nominal association (P,0.01) in our GWAS (Figure S3).
SNPs located in eight regions with p-values ,0.05 were
previously identified in a combined analysis of an international
cohort of Caucasian KD patients and in a family-based KD cohort
[13]. Therefore, we further examined the SNPs from these gene
regions that were included in our GWAS. Our results showed that
none of these SNPs had 2log10 (pbest) values greater than 4.
However, 10 and 42 SNPs in NAALADL2 (N-acetylated alpha-
linked acidic dipeptidase-like 2) and CSMD1 (CUB and Sushi
multiple domains) regions, respectively, showed a nominal
association with KD (p,0.01) in our GWAS (Figure S4).
Discussion
To the best of our knowledge, this study is the first report of a
GWAS for KD conducted in a Han Chinese population. In this
study, we identified novel candidates associated with KD
susceptibility. The identification of these genes may provide new
insights into the development of KD.
Three KD-associated SNPs—rs1873668, rs4243399, and
rs16849083—are located in the same LD of chromosome 3q23
region, which contains three genes. The head-to-tail overlapping
genes MRPS22 and COPB2 are located nearest to rs1873668 and
rs4243399, whereas rs16849083 is located in the intronic region of
PBP2. Mutations in MRPS22, a mitochondrial ribosomal protein,
lead to antenatal mitochondrial disease, which presents with
antenatal skin edema, hypotonia, cardiomyopathy, and tubulo-
pathy [18]. PBP2 is thought to participate in the uptake and/or
intracellular metabolism of vitamin A. The roles of NRPS22 and
PBP2 have no obvious connection to the pathogenesis of KD.
COPB2 constitutes the coat of nonclathrin-coated vesicles and is
essential for Golgi budding and vesicular trafficking. A phospho-
proteomic analysis of T cell receptor signaling, which identified
proteins involved in receptor and membrane trafficking in
endosomes and vesicles playing a role in T cell receptor signaling
and critical for T cell activation [19]. The possibility of COPB2
involvement in T cell activation and KD pathogenesis will require
further investigation.
We identified two KD-associated SNPs, rs149481 and rs27042,
located in an intron of the ERAP1 gene. ERAP1 plays a critical
role in trimming peptides to the optimal length for HLA class I
presentation [20] and cleaving cell surface receptors for
proinflammatory cytokines. It is ubiquitously expressed in every
tissue, and is expressed at higher levels in the trachea, thymus,
and lymph nodes (based on a National Center for Biotechnology
Information [NCBI] expressed sequence tags profile). From a
functional perspective, ERAP1 represent an excellent biological
candidate for KD pathogenesis. ERAP1 trimming of peptides for
HLA class I presentation could play a critical role in initiating the
immune response. Furthermore, ERAP1 cleaves cell surface
receptors for the proinflammatory cytokines IL-1 [21], IL-6 [22],
and TNF [23], thereby downregulating their signaling. Genetic
variants that alter the functioning of ERAP1 could, therefore,
have proinflammatory effects through this mechanism. In
Figure 1. Graphical summary of KD GWAS in a Han Chinese population. KD association was determined for SNPs on the Affymetrix SNP6.0
chip. The y-axis represents the 2log10 p-value, and the x-axis represents each of the 723,638 SNPs used in the primary scan of 250 KD cases and 446
controls.
doi:10.1371/journal.pone.0016853.g001
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have been found to be associated with ankylosing spondylitis, an
HLA class I–mediated autoimmune disease, and enthesitis, a
common inflammatory arthritis characterized by axial skeletal
inflammation [24]. We did not identify any significant SNPs in
the HLA region in our GWAS, suggesting that augmentation of
proinflammatory cytokine signaling through ERAP1 is more
likely involved in KD. However, the association between HLA
and KD remains inconclusive. Some SNPs located in HLA-A and
HLA-B regions did show a nominal association (p,0.01) in our
study. Determining whether HLAs play a role in KD suscepti-
bility will require further investigation in a larger sample size
using a traditional HLA genotyping method. Clarifying a
potential association between HLA and KD will also help to
elucidate the involvement of an ERAP1 downstream mechanism
in KD.
We found that a cluster of SNPs located in chromosome 14
immunoglobulin heavy chain variable regions exhibited the
strongest association in the joint analysis. The heavy chain
molecule is a major contributor to the generation of immuno-
globulin diversity and specificity. Therefore, in addition to cell-
mediated immunity, antibody-mediated immunity may be critical
in KD pathogenesis. IgA plasma cells infiltrate inflamed tissues,
including coronary arteries, in acute KD [25,26], and oligoclonal
KD antibodies bind to an antigen in acute KD-inflamed ciliated
bronchial epithelium [27]. Specific immunoglobulins produced by
particular heavy chain recombinants following a KD antigen
trigger could play a role in KD pathogenesis. Identification of
these specific antibodies could lead to the elucidation of disease-
relevant mechanisms and potential treatments.
We also performed a haplotype analysis, identifying two
haplotypes with p-values ,10
25. The significance of these two
haplotypes, however, was mainly contributed by single SNPs
showing strong associations in single-point analyses. Also, the
haplotype frequencies were less than 0.05. Accordingly, we could
not exclude the possibility that the significant p-values and the
small differences between the haplotype frequencies of cases and
controls might have resulted from estimation errors, given the
small sample sizes. Additional analyses with larger numbers of
subjects are warranted.
The major limitation of this study is that the low sample size,
which reflected the difficulties inherent in recruiting patients with
such a rare disease, could only reach a statistical power of 0.78 to
detect a disease allele with a frequency of 0.10 and a relative risk of
3.0, assuming a disease incidence of 0.01% under an additive
model. Also, the small sample size is underpowered to detect very
small effects. With the additional replication sample, the joint
analysis marginally strengthened some of the SNPs in the GWAS.
Many of the significantly associated SNPs in the discovery phase
were either insignificant or of marginal significance in the
replication phase. This raises the possibility of false positives, a
problem common to all GWAS. Replication of the findings in
large, well-powered independent samples is crucial if this problem
is to be overcome, and will likely require a multicenter
collaboration. Such an increase in the size of the study cohorts
would also make it possible to detect smaller effects. In addition,
we found a higher proportion of male KD patients than controls in
our study because of the higher incidence of KD in males.
Although it is unclear whether and how this might have affected
the results, it could have led to some degree of bias. Several genes
implicated in previous candidate gene studies were not shown to
have 2log10 (pbest) values greater than 4 in our studies, probably
due to difference in the relative importance of particular genetic
variants in determining susceptibility to complex diseases among
different ethnic groups or ethnicity-linked haplotype structures.
However, some of the SNPs located in the candidate gene regions
did show a KD association with p-values ,0.01. Further
replication with a larger sample size and different populations
would be helpful in evaluating the involvement of these genes in
the susceptibility of KD.
In summary, we conducted a GWAS for KD in a Han Chinese
population. Ten SNPs located in three novel loci were found to be
associated with KD in this population. The novel KD risk loci
contained genes that have been implicated in T cell receptor
signaling, proinflammatory cytokine regulation, as well as
antibody-mediated immune responses. Our results suggest that
antigen initiation, uncontrolled inflammation, and antibodies are
involved in the pathogenesis of KD, findings that may provide new
directions for future studies. In particular, further characterization
of causative variants and elucidating their mechanisms of action
may lead to the identification of novel diagnostic and therapeutic
targets for KD.
Materials and Methods
Ethical statement
The study was approved by the Institutional Review Board and
the Ethics Committee of the Institution Review Board of China
Medical University Hospital, National Taiwan University Hospi-
tal, Changhua Christian Hospital, Taipei Veterans General
Hospital, Kaohsiung and Linkou Chang Gung Memorial
Hospital, Mackay Memorial Hospital, and Academia Sinica,
Taiwan. Written informed consent was obtained from the subjects
or their parents in accordance with institutional requirements and
the Declaration of Helsinki principles.
Study subjects and phenotype definition
Unrelated patients with KD (n=250) were consecutively
recruited from China Medical University Hospital in Taichung,
Taiwan, in collaboration with the National Clinical Core (NCC) of
Taiwan. There were 156 males (62.4%) and 94 females (37.6%)
(Table S2), with an average age at onset of 1.7661.61 years. The
208 KD patients for the follow-up validation study were recruited
from China Medical University Hospital in Taichung, National
Taiwan University Hospital in Taipei, Changhua Christian
Hospital in Changhua, Taipei Veterans General Hospital in
Taipei, and Chang Gung Memorial Hospital in Kaohsiung and
Linkou, Taiwan. There were 142 males (68.3%) and 66 females
(31.7%) in this second study group (Table S2). All patients were
diagnosed according to criteria for KD [28,29], including fever
lasting 5 d or more and at least four of the following symptoms: (1)
changes in extremities (e.g., erythema, edema, desquamation), (2)
bilateral conjunctival injection, (3) polymorphous rash, (4) cervical
lymphadenopathy, (5) changes in lips or oral cavity (e.g.,
pharyngeal erythema, dry/fissured or swollen lips, strawberry
tongue). Only Han Chinese individuals, who account for 98% of
Figure 2. LD structure and association results for disease-association regions. The 2log10 p values (left y-axis) for the best test from the
primary scan were plotted as a function of genomic positions based on NCBI Build 36. The SNPs with the strongest signals in the joint analysis are
denoted by blue diamonds. Estimated recombination rates (right y-axis) based on the Chinese HapMap population are plotted in blue across the
region to reflect the local LD structure around the significant SNPs. Gene annotations were taken from NCBI.
doi:10.1371/journal.pone.0016853.g002
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background was assigned based on self-report questionnaires.
Members of the control groups (446 in the GWAS study and 366
in the follow-up study) were randomly selected from the Taiwan
Han Chinese Cell and Genome Bank in Taiwan, as reported
previously [30]. The prevalence of KD in the Taiwan population
is less than 0.01%; hence, the controls were presumably disease
free.
Genotyping and quality control
Genomic DNA was extracted from patient blood using the
Puregene DNA Isolation Kit (Gentra Systems, Minneapolis, MN,
USA). Each individual was genotyped by the National Genotyping
Center at Academia Sinica, Taipei, Taiwan using the Affymetrix
Genome-Wide Human SNP Array 6.0, containing a total of
906,600 SNPs, according to the manufacturer’s protocols.
Genotype calls were made using the BRNNP algorithm imple-
mented in Genotype Console, with default parameters suggested
by the platform manufacturer. All sample call rates were greater
than 0.95, and the average call rate of the sample was 0.993
(SD=0.005). Genotype data was quality controlled by examining
several summary statistics. First, the total call rate (successful call
rate) and MAF of cases and controls was calculated for each SNP.
SNPs were excluded for further analysis if one of following
conditions occurred: (1) only one allele appeared in cases and
controls; (2) the total call rate was less than 0.95; or (3) the total
MAF was less than 0.05 and the total call rate was less than 0.99.
SNPs that significantly departed from Hardy–Weinberg equilib-
rium proportions (p,10
27) were also excluded.
Population stratification
Possible population stratification that could influence associa-
tion analyses was detected using multidimensional scaling analysis
implemented in PLINK (http://pngu.mgh.harvard.edu/purcell/
plink [30]). We also estimated the variance inflation factor for
genomic control.
Genome-wide association analysis
GWAS was carried out to compare allele/genotype frequencies
between cases and controls using genotype, allele type, and
Cochran–Armitage trend tests, and tests considering dominant
and recessive inheritance modes. After applying these five single-
point methods, quantile–quantile (Q–Q) plots were used to
examine p-value distributions (Figure S5). Two-point analyses
were performed using a logistic regression model, regressing the
affected status of two SNPs and their interaction. SNPs were coded
as 0, 1, and 2 for the number of minor alleles and were treated as
continuous variables.
Validation and replication
The top SNPs (p,10
24) from the GWAS in the 250 cases and
446 controls were further validated using matrix-assisted laser
desorption/ionization-time of flight (MALDI-TOF) mass spec-
trometry (Sequenom MassARRAY; Sequenom, San Diego, CA,
USA). SNPs retained after cross-platform validation were then
genotyped in an additional 208 cases and 366 controls for
replication.
Supporting Information
Figure S1 Multidimensional scaling analysis plot. (A)
Multidimensional scaling (MDS) plot of the first two principal
components estimated by PLINK, based on the genotype data of
100,000 SNPs with equal spacing across the human genome
randomly selected from 723,638 high-quality SNPs in KD cases
and controls with HapMap3 genotype data was presented. (B) The
results of KD cases and controls shown separately. No population
stratification between the 250 KD cases (red) and 446 controls
(blue) was detected (p = 0.460).
(TIFF)
Figure S2 Linkage disequilibrium plot of disease-asso-
ciation regions. The upper panel shows –log10 (p-values) of
SNPs for the best test from the primary scan as a function of
genomic positions for (A) COPB2, (B) ERAP1, (C) IGHV regions
(based on NCBI Build 36). Also shown are the relative positions of
genes that map to each region of association. The SNPs with the
strongest signal in the joint analysis are denoted by red diamonds.
In the lower panel are the estimated statistics of the square of the
correlation coefficient (r
2), derived from genotypes in our GWAS.
The values indicate the LD relationship between each pair of
SNPs shown within each diamond. Red diamonds without
numbers represent D’ = 1.
(TIFF)
Figure S3 Comparisons with previously identified KD
susceptibility gene regions. Comparison of results for KD
susceptibility gene regions encoding (A) HLA-A, (B) HLA-B, and
(C) TNF-a, reported in previous candidate gene studies, and (D)
ITPKC identified in a genome-wide linkage study, to those in the
current study. Triangles represent the 2log10 of the minimal
p-values for the SNPs in the gene region and within a 6200-kb
region, based on the initial analysis of 250 KD cases and 446
controls. Also shown are the relative positions of genes that map to
each region of association (based on NCBI Build 36). In the lower
panel is the estimated square of the correlation coefficient (r
2),
derived from phase-2 genotypes in CHB and JPT in Haploview
software (v4.1). The red diamonds indicate the LD relationship
between each pair of SNPs as D’ = 1.
(TIFF)
Figure S4 Comparisons to previous GWAS. Comparison
of the present results for KD susceptibility gene regions (A)
NAALADL2 and (B) CSMD1 to those reported by previous
GWAS. Squares represent the 2log10 of the minimal p-values of
the SNPs in the gene region, based on the initial analysis of 250
KD cases and 446 controls. Also shown are the relative positions of
genes that map to each region of association (based on NCBI Build
36). In the lower panel is the estimated square of the correlation
coefficient (r
2), derived from phase-2 genotypes in CHB and JPT
in Haploview software (v4.1). The values indicate the LD
relationship between each pair of SNPs shown within each
diamond. Red diamonds without numbers represent D’ = 1. The
same SNPs genotyped in the previous GWAS and in our GWAS
are denoted by red diamonds in the upper panel and a red
rectangle in the lower panel.
(TIFF)
Figure S5 Q–Q plot for the trend test. Q–Q plots are shown
for the trend test based on the 723,638 high-quality SNPs of the
initial analysis with 250 cases and 446 controls. Blue lines
represent the upper and lower boundaries of the 95% confidence
interval bands. Black dots showing deviations from the line of
equality indicate either that the theoretical distribution was
incorrect, or that the sample was contained within values
generated by a true association.
(TIFF)
Table S1 Quality control of participant data.
(PDF)
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Table S3 Association results and concordance rates for
validated, significantly associated SNPs in the initial
cohort, and association results from the replication
study.
(PDF)
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